Skip to main content

Advertisement

Table 4 Indirect comparison of hazard ratios for risk of relapse

From: Long-acting injectable paliperidone palmitate versus oral paliperidone extended release: a comparative analysis from two placebo-controlled relapse prevention studies

  PP Paliperidone ER PP placebo Paliperidone ER placebo
  (n= 193) (n= 104) (n= 192) (n= 101)
Subjects with events, n (%) 32 (17) 23 (22) 90 (47) 52 (51)
Hazard ratio (95% CI)a 2.52 (1.46 to 4.35) 2.25 (1.59 to 3.18)
  1. aHazard ratios reflect paliperidone ER/PP for active treatments and placebo treatments, respectively. CI confidence interval, ER extended release, PP paliperidone palmitate.